<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109145">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01756664</url>
  </required_header>
  <id_info>
    <org_study_id>Siriraj-Eucerin01</org_study_id>
    <secondary_id>SI402/2012</secondary_id>
    <nct_id>NCT01756664</nct_id>
  </id_info>
  <brief_title>The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing</brief_title>
  <official_title>The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing - A Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      - The use of sunscreen on the first day after fractional ablative skin resurfacing may
      reduce the risk of post-inflammatory hyperpigmentation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  The use of sunscreen on the first day after fractional ablative skin resurfacing may
           reduce the risk of post-inflammatory hyperpigmentation (PIH)

        -  Therefore, we conducted the study to evaluate the efficacy of the use of sunscreen on
           the first day after fractional ablative skin resurfacing in reducing the risk of PIH.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Melanin Index</measure>
    <time_frame>3 Month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Erythema Index</measure>
    <time_frame>3 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Transepidermal Water Loss</measure>
    <time_frame>1 Week</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>PIH</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Vaseline has been used on the first day after laser treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sunscreen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sunscreen has been used on the first day after laser treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sunscreen</intervention_name>
    <arm_group_label>Sunscreen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vaseline</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who want to receive fractional ablative laser resurfacing for acne scars

        Exclusion Criteria:

          -  Pregnancy

          -  Lactation

          -  Age &lt; 18
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rungsima Wanitphakdeedecha, MD</last_name>
    <email>rungsima.wan@mahidol.ac.th</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rungsima Wanitphakdeedecha, MD</last_name>
      <email>rungsima.wan@mahidol.ac.th</email>
    </contact>
    <investigator>
      <last_name>Rungsima Wanitphakdeedecha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>December 26, 2012</lastchanged_date>
  <firstreceived_date>December 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Petrolatum</mesh_term>
    <mesh_term>Sunscreening Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
